Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,566 | 11,213 | 9,167 | 8,261 | 7,349 |
| Cost of Goods | 1,906 | 1,802 | 1,495 | 1,216 | 1,004 |
| Gross Profit | 9,660 | 9,411 | 7,672 | 7,045 | 6,345 |
| Operating Expenses | 19,580 | 17,545 | 15,496 | 14,841 | 15,088 |
| Operating Income | -9,014 | -7,332 | -7,329 | -7,580 | -8,739 |
| Interest Expense | 1,460 | 1,423 | 1,209 | 1,068 | 1,142 |
| Other Income | -332 | 464 | -1,832 | -1,461 | 7,479 |
| Pre-tax Income | -10,806 | -8,291 | -10,370 | -10,109 | -2,402 |
| Income Tax | -5 | 3 | -5 | 13 | 3 |
| Net Income Continuous | -10,801 | -8,294 | -10,365 | -10,122 | -2,405 |
| Net Income | $-10,811 | $-8,288 | $-10,375 | $-10,108 | $-2,399 |
| EPS Basic Total Ops | -0.96 | -0.27 | -0.39 | -0.38 | -0.12 |
| EPS Basic Continuous Ops | -0.25 | -0.25 | -0.36 | -0.35 | -0.09 |
| EPS Diluted Total Ops | -0.96 | -0.27 | -0.39 | -0.38 | -0.12 |
| EPS Diluted Continuous Ops | -0.25 | -0.25 | -0.36 | -0.35 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -0.27 | -0.33 | -0.35 | -0.40 |
| EBITDA(a) | $-8,576 | $-6,910 | $-6,922 | $-7,209 | $-8,390 |